Chrishan Anketell

Stock Analyst at Aegis Capital

(n/a)
# 4,350
Out of 4,711 analysts
1
Total ratings
n/a
Success rate
-58.26%
Average return
Main Sectors:
Top Industries:

Stocks Rated by Chrishan Anketell

Can-Fite BioPharma
Jun 24, 2021
Initiates: Buy
Price Target: $50
Current: $1.47
Upside: +3,301.36%